Dr. Dilip Kumar

About us

"Advancing Heart Care with Compassion, Precision, and Innovation"

Dr. Dilip Kumar

Director-Cardiac Cath Lab
Complex Coronary, Device & Structural Heart Expert in Eastern India
Chief Academic Co-Ordinator Medica Institute of Cardiac Science

MBBS, MD(Medicine), DM( Cardiology), FACC, FRCP (GLAS), FSCAI, FESC, FICC, FHRS

Certified Cardiac Device Specialist (CCDS,HRS,USA)

Experience

Jan 2010 – Present

  • Senior Consultant Interventional Cardiologist, Medica Superspecialty Hospital, Kolkata (Over 15 Years of Experience)
  • Director, Cardiac Cath Lab Services (Medica Institute of Cardiac Science)

Fellowships

  • HEART RHYTHM SOCIETY, USA
  • SOCIETY OF CARDIOVASCULAR ANGIOGRAPHY & INTERVENTIONS, USA
  • ROYAL COLLEGE OF PHYSICIANS - (GLASG.)
  • EUROPEAN SOCIETY OF CARDIOLOGY
  • INDIAN COLLEGE OF CARDIOLOGY
  • AMERICAN COLLEGE OF CARDIOLOGY
  • HEART FAILURE ASSOCIATION

Professional Memberships

  • Fellow of the Society for Cardiovascular Angiography & Interventions (FSCAI)
  • Fellow of the European Society of Cardiology (FESC)
  • Fellow of the Heart Rhythm Society (FHRS)
  • Fellow of the Society of Cardiac Angiography & Interventions (FSCAI)
  • Fellow of the American College of Cardiology (FACC)
  • Fellow of the Indian College of Cardiology (FICC)
  • Fellow of the Heart Failure Association (HFA)

Awards & Honours

  • One of the largest experiences of Device Implantations in India
  • Multiple publications in National and International Journals
  • University Topper in DM Cardiology, WBUHS, 2007
  • Winner of the National Postgraduate Quiz at Varanasi 2003 (APICON)
  • Healthcare Pioneers of the East (2020) Award by Times Group (Feb 26, 2020)
  • Pioneer in Structural Heart Interventions in Eastern India

Research

  • Principal Investigator in multiple clinical trials (IBIS, PRESCO, TUXEDO, etc.)
  • Numerous peer-reviewed publications in leading cardiology journals
  • TUXEDO STUDY
  • Principal Investigator in LIFELEAV WACHT study (ongoing)
  • HEART FAILURE REGISTRY (ongoing)
  • Principal Investigator of EVER MINE STENT Phase III trial
  • Principal Investigator in PEACH F trial
  • Co-Investigator in GLOBAL DECICATE Registry (ongoing)
  • Author of book chapters and yearbooks in cardiology

Publications

  • Real-world, prospective, multi-center, randomized study to assess possible benefits of engaging patients Post Percutaneous Coronary Intervention (PCI) through WhatsApp-based Interactive Platform and Remote Nursing (E-monitor); December 2024. Indian Heart Journal 76:S32; DOI:10.101016/j.ihj.2024.11.069
  • Year Book of Cardiology 2024 Hypertension
  • TCT -196 Real-World, Prospective, Multicenter, Randomized Study to Assess Possible Benefits of Engaging Patients Post Percutaneous Coronary Intervention (PCI) Through WhatsApp-Based Interactive Platform and Remote Nursing (E-Monitor); October 2024. Journal of the American College of Cardiology 84(18):B14; DOI:10.1016/jacc.2024.09.232
  • Left Bundle Branch Pacing in a Patient with Dextroposed Heart: A Case Report; September 2024
  • Clinical safety and performance of the world’s thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES-1 study; September 2024. AsiaIntervention 10(3):195-202; DOI:10.4244/AIJ-D-24-00009
  • Incidence of Coronary Artery Disease after Permanent Pacemaker Implantation: A Hospital-based Study from East India (online) CC by 4.0 license; June 2024. Journal of Innovations in Cardiac Rhythm Management 15(6):5911-5916; DOI:10.19102/icrm.2024.15065
  • Precious twins and a precarious heart: Treating severe mitral stenosis in a high-stakes twin pregnancy - a case report; June 2024; DOI:10.1016/ihjcvr.2024.06.005
  • Two-Stent Strategy for Bifurcation Lesions in Percutaneous Transluminal Coronary Angioplasty: Real-World Evidence; January 2024. World Journal of Cardiovascular Diseases; DOI:10.4236/wjcd.2024143012
  • Fenestration - Integrating Wings Into the Atrial Septal Occluder for Navigating a Challenging Terrain; September 2023. Cureus 15(9); DOI:10.7759/cureus.45260
  • Case Series LOT-CRT in Patients with Refractory Heart Failure and Non-LBBB Morphology: A Case Series; September 2023; DOI:10.4103/HFJI.HFJI_46_23
  • Real World Evidence of Bempedoic Acid on Efficacy and Safety in Patients with Uncontrolled LDL-c and at High Risk of CVD. June 2023. Cardiology and Angiology An International Journal; DOI:10.9734/ca/2023/v12i4350
  • Permanent Pacemakers and Defibrillators; May 2023
  • Real World Evidence of Bempedoic Acid on Efficacy and Safety in Patients with Uncontrolled LDL-c and at High Risk of CVD; January 2023
  • Clinical expert consensus document on the use of percutaneous left ventricular assist devices during complex high-risk PCI in India using a standardised algorithm; October 2022. AsiaIntervention 8(2):75-85
  • Left Bundle Branch Pacing in a Scoliosis Patient with Symptomatic Brady-arrhythmia: A Case Report International Journal of Science and Research (IJSR) ISSN: 2319-7064 SJIF (2020): 7.803 Volume 10 Issue 5, May 2021
  • Long term clinical outcomes of thrombus aspiration in STEM patients undergoing primary percutaneous coronary intervention JUNE 2020 Am J Cardiovasc Dis 2020;10(2):117-123
  • Consensus and development of document for management of stabilized acute decompensated heart failure with reduced ejection fraction in India, Volume 72, Issue 6 November–December 2020, Pages 477-481 (Indian Heart Journal 72 (2020) 477e481)
  • Procedural safety and outcome of ultrathin strut stent (<60µm) in the management of very long coronary artery stenosis (>30mm) - a retrospective real world study. Am J Cardiovasc Dis 2020;10(3):182-188
  • Endovascular stent-graft repair of an asymptomatic large splenic artery aneurysm. IHJ Cardiovascular Case Reports 2020,4(2); 65-67
  • Strontium in atrioventricular conduction disorder: Is it a new target? J Indian Coll Cardiol 2020. DOI: 10.4103/jicc.jicc_82_20 volume Suppl s1 page 36/37 publication year 2019

Vision
To be a leading force in the field of interventional cardiology and electrophysiology, delivering world-class, innovative cardiac care that transforms lives and sets new standards of excellence in healthcare across India and beyond.
Mission
  • To provide comprehensive, patient-centered cardiovascular care using advanced technology and techniques, with a focus on safety, precision, and compassion.
  • To lead the field in structural heart disease interventions and electrophysiology by continuously updating clinical practices with the latest medical research and innovations.
  • To educate and inspire the next generation of cardiologists through active academic involvement and mentorship, fostering excellence in clinical practice.
  • To promote heart health awareness and preventive care, empowering individuals to take control of their cardiovascular well-being for a healthier future.